Epic Update : Claris Lifesciences

Claris Lifesciences (Claris) has received two abbreviated new drug application (ANDA) approvals for Ondensetron Injection in the United States of America (US). Ondansetron Injection is indicated for prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including high-dose cisplatin and for prevention of postoperative nausea and/or vomiting.

Get Free MCX Tips, Stock Tips, Forex Tips & NCDEX Tips,Commodity Tips, Share Tips, commodity tips free trial, nifty free tips, commodity trading tips, shares tips, Share Market Tips, Stock Market Tips, free stock tips on mobile, Stock trading tips, Intraday Tips.